Navigation Links
Schering-Plough to Webcast Presentation at 27th Annual J.P. Morgan Healthcare Conference
Date:1/9/2009

KENILWORTH, N.J., Jan. 9 /PRNewswire-FirstCall/ -- Schering-Plough Corporation (NYSE: SGP) will provide a live audio webcast of a presentation by Thomas P. Koestler, Ph.D., executive vice president and president, Schering-Plough Research Institute, at the 27th Annual J.P. Morgan Healthcare Conference in San Francisco on Monday, Jan. 12, at approximately 3:30 p.m. (PST) (6:30 p.m. EST). Koestler is expected to talk about the company's R&D pipeline and select projects in development.

A live audio webcast of the presentation will be available by going to the Investor Relations section of the Schering-Plough corporate Web site, www.schering-plough.com, and clicking on the "Presentations/Webcasts" link. A replay of the webcast will be available later that day.

Schering-Plough is an innovation-driven, science-centered global health care company. Through its own biopharmaceutical research and collaborations with partners, Schering-Plough creates therapies that help save and improve lives around the world. The company applies its research-and-development platform to human prescription, animal health and consumer health care products. Schering-Plough's vision is to "Earn Trust, Every Day" with the doctors, patients, customers and other stakeholders served by its colleagues around the world. The company is based in Kenilworth, N.J., and its Web site is www.schering-plough.com.


'/>"/>
SOURCE Schering-Plough Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. HUYA Bioscience Announces Agreement to Provide Schering-Plough With Drug Development Candidates From China
2. Schering-Plough Declares Quarterly Dividends on Common Shares and 2007 Mandatory Convertible Preferred Stock
3. Schering-Plough Reschedules Time of Conference Call, Webcast for 2008 Second Quarter Earnings to Later Today
4. Schering-Plough Announces Closing of Planned Divestiture of Selected Animal Health Products
5. Schering-Plough Declares Quarterly Dividends on Common Shares and 2007 Mandatory Convertible Preferred Stock
6. Schering-Plough Schedules Conference Call and Webcast for 2008 Second Quarter Earnings
7. Schering-Plough Appoints Janet M. Barth Vice President, Investor Relations
8. Schering-Plough Schedules Webcast for Annual Meeting of Shareholders
9. Intervet/Schering-Plough Animal Health Outlines Strength of the Combination
10. Schering-Plough/MERCK Pharmaceuticals Receives Not-Approvable Letter from FDA for Loratadine/Montelukast
11. Schering-Plough CEO Buys $2 Million in Common Shares
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)...  The Council for Entrepreneurial Development (CED), the ... country, today released a mid-year update to its ... It showed that in the first half of ... in the technology, life science, advanced manufacturing and ... variety of sources. Significant investment in technology companies and ...
(Date:9/16/2014)... September 16, 2014 Convoy Therapeutics, ... and effective products to treat patients directly at ... a proprietary SPACEā„¢ Technology Platform announced today that ... will present at the White Hat Life Science ... Hyatt Regency Phoenix. In addition, interested individuals ...
(Date:9/16/2014)...  Ascendis Pharma A/S, a biotechnology company that ... unmet medical needs, today announced positive interim results ... evaluate once-weekly TransCon Growth Hormone in children with ... results will be presented at the 7th International ... held October 15-18, 2014, in Singapore.  ...
(Date:9/16/2014)... 16, 2014 According to Jeff Howell, ... of ITRA Global, new development in Downtown Toronto is ... council approving another 755 storeys of new development last ... cranes will be dominating the Toronto skyline for the ... an unquenchable thirst for new development. , As the ...
Breaking Biology Technology:CED's Mid-Year Update to its Innovators Report Shows NC Startups Attracting Investment From Across the Globe with Several High-Profile Investment Deals, IPOs and Acquisitions Signaling Strength of Entrepreneurial Sector 2CED's Mid-Year Update to its Innovators Report Shows NC Startups Attracting Investment From Across the Globe with Several High-Profile Investment Deals, IPOs and Acquisitions Signaling Strength of Entrepreneurial Sector 3CED's Mid-Year Update to its Innovators Report Shows NC Startups Attracting Investment From Across the Globe with Several High-Profile Investment Deals, IPOs and Acquisitions Signaling Strength of Entrepreneurial Sector 4Convoy Therapeutics to Present at WhiteHat Investor Conference September 18, 2014 2Convoy Therapeutics to Present at WhiteHat Investor Conference September 18, 2014 3Ascendis Pharma A/S Announces Positive Interim Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 2Ascendis Pharma A/S Announces Positive Interim Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 3Ascendis Pharma A/S Announces Positive Interim Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 4ITRA Global Reports Downtown Toronto Real Estate Development is in High Gear 2ITRA Global Reports Downtown Toronto Real Estate Development is in High Gear 3
... ... and Roles , ... Canberra, Australia (Vocus) October 27, 2009 -- Global food security, which is increasingly being ... and executed public and private partnerships, William S. Niebur , vice president – ...
... Oct. 27 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. (TSX: ... that it has been granted its 33rd U.S. ... Resistant Neoplastic Cells With a Virus." The patent ... with currently approved chemotherapeutic agents to treat patients ...
... Oct. 27 Precision Antibody(TM) has been selected ... National Cancer Institute (NCI),s Clinical Proteomic Technologies for Cancer ... standardizing the quality of monoclonal antibody reagents available for ... result of a third solicitation for contract proposals from ...
Cached Biology Technology:Public-Private Partnerships Key to Achieving Global Food Security, Says DuPont Leader 2Public-Private Partnerships Key to Achieving Global Food Security, Says DuPont Leader 3Oncolytics(R) Biotech Inc. Announces Issuance of 33rd U.S. Patent 2Precision Antibody Wins Contract to Develop 'Gold Standard' Antibodies as Part of National Cancer Institute's Clinical Proteomics Technologies for Cancer (CPTC) Initiative 2Precision Antibody Wins Contract to Develop 'Gold Standard' Antibodies as Part of National Cancer Institute's Clinical Proteomics Technologies for Cancer (CPTC) Initiative 3
(Date:9/16/2014)... 2014)The North American Menopause Society (NAMS) has published ... of midlife womenon everything from hot flashes to ... Menopause Society Recommendations for Clinical Care of Midlife ... journal Menopause . This is the first, ... of midlife women freely available to all clinicians ...
(Date:9/16/2014)... September 13, 2014. The fire is human-caused and ... acres in size and is mostly being fueled by ... Monday night due to higher humidity. Yesterday (8/15), ... to construct a fireline on the West and North sides ... the fire: , 7 20-person Crews, 4 Hot Shot Crews, ...
(Date:9/16/2014)... has its own bacterial identity. That,s the conclusion of ... who studied the genetic fingerprints of bacteria on 57 ... "This study demonstrates for the first time that host ... strategies possess very different microbial communities on their leaves," ... researcher in the UO,s Institute of Ecology and Evolution ...
Breaking Biology News(10 mins):Microbiome research shows each tree species has a unique bacterial identity 2
... of Leicester have identified for the first time a new ... in our blood following a meal. They have ... to maintain correct blood sugar levels. The breakthrough was ... by Professor Andrew Tobin, Professor of Cell Biology, who is ...
... of many countries in Europe and Asia. Great Tits ... long been known individuals vary considerably in their willingness to ... or "proactive" are quick explorers and are comparatively aggressive, ... differences are at least in part genetically determined and as ...
... be able to receive more effective, personalized treatments for ... cancer biology, experts will say at the Cancer Biology ... Medical Oncology (ESMO) in Nice this week. ... transformation, governments, pharmaceutical companies and doctors urgently need to ...
Cached Biology News:Bird-brained? Birds' personalities are correlated with their hormone levels 2New strategies for cancer drug development urgently needed 2New strategies for cancer drug development urgently needed 3
Request Info...
... Tissue Array (MSTA) slides were designed to study ... from multiple species. Tissue slices from three ... which can then be treated as a single ... in situ hybridization. This format allows ...
... Pulser Xcell microbial system, 100 to ... for electroporation of bacterial and fungal ... unit, PC module for exponential decay ... cuvettes (5 each of 0.1 and ...
... (TSB), USP is a highly nutritious versatile ... use. Due to the inclusion of both ... support growth of many fastidious organisms without ... conforms to United States Pharmacopeia standards for ...
Biology Products: